Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses

NCT03808571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2019-01-22

No results posted yet for this study

Summary

: The aim of this study is to investigate Cord blood irisin and nesfatin-1 levels in pregnancies with intrauterine growth retardation and to determine whether they are associated with abnormal fetal doppler findings or not.

Conditions

  • Nesfatin-1
  • Irisin
  • Intrauterine Growth Restriction

Interventions

OTHER

cord blood specimen during the delivery

The cord blood will be taken during the delivery of baby.

Sponsors & Collaborators

  • Yuzuncu Yıl University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-01-10
Completion
2019-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03808571 on ClinicalTrials.gov